Barr Nortrel 7/7/7
Executive Summary
Patent suit regarding Ortho McNeil's Ortho-Novum 7/7/7 oral contraceptive will go to trial in the New Jersey federal court by late summer or early fall, Barr says. The patent for the norethindrone-ethinyl-estradiol 7/7/7 combination expires in September 2003. Ortho McNeil's 30-month stay under Paragraph IV certification expires in June